论文信息 - Aprotinin use in patients with dialysis-dependent renal failure undergoing cardiac operations. - 字舞流文

Aprotinin use in patients with dialysis-dependent renal failure undergoing cardiac operations.

W. Long | M. Metzdorff | J. Lemmer | J. Okies | U. Page | A. Krause | J. Hill | T. Winkler | T. Molloy

[1] R. E. Clark,et al. A multicenter, double-blind, placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting. , 1995, Circulation.

[2] C. H. Owen,et al. Coronary artery bypass grafting in patients with dialysis-dependent renal failure. , 1994, The Annals of thoracic surgery.

[3] Y. Tsutsumi,et al. [A case report of coronary artery bypass grafting surgery with aprotinin in a patient undergoing chronic haemodialysis]. , 1994, Kyobu geka. The Japanese journal of thoracic surgery.

[4] C. Tatooles,et al. Aprotinin for coronary bypass operations: efficacy, safety, and influence on early saphenous vein graft patency. A multicenter, randomized, double-blind, placebo-controlled study. , 1994, The Journal of thoracic and cardiovascular surgery.

[5] L. Berkowitz,et al. Hemostasis in renal disease: pathophysiology and management. , 1994, The American journal of medicine.

[6] O. Isom,et al. Cardiopulmonary bypass procedures in dialysis patients. , 1993, The Annals of thoracic surgery.

[7] P. Sobotka,et al. Internal mammary artery revascularization in the patient on long-term renal dialysis. , 1990, The Annals of thoracic surgery.